Position in MRNA
as of Mar 31, 2026
· filed Apr 14, 2026
Position Value
$139,636,703
+$47,311,653 QoQ
Shares Held
2,748,754
-12.2% QoQ
Ownership
0.693%
of shares outstanding
% of Portfolio
1.79%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Derivatives in MRNA
reported options exposure · as of Jun 30, 2024CallValue
$0
CallShares
0
PutValue
$1,229,181
PutShares
10,351
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANQUE PICTET & CIE SA holds $180,153,862 across 15 Biotechnology names. MRNA ranks #1 (77.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
This page
|
2,748,754 | $139,636,703 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
28,550 | $12,748,717 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
9,893 | $7,643,727 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
61,846 | $3,593,871 | |
| 5 | GPCR |
Structure Therapeutics Inc.
|
49,367 | $2,379,489 | |
| 6 | IMVT |
Immunovant, Inc.
|
88,660 | $2,202,314 | |
| 7 | AVIR |
Atea Pharmaceuticals, Inc.
|
345,077 | $1,856,514 | |
| 8 | BNTX |
BioNTech SE
|
19,677 | $1,748,891 |
All Filings in MRNA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $139,636,703 | 2,748,754 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $92,325,050 | 3,130,724 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $80,866,600 | 3,130,724 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $86,438,752 | 3,132,974 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $88,819,812 | 3,132,974 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $130,269,058 | 3,132,974 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $210,875,315 | 3,155,399 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $374,588,443 | 3,154,429 | Shares | Sole | 2024-07-25 | |
| 2024-06-30 | $1,229,181 | 10,351 | Put | Sole | 2024-07-25 | |
| 2024-03-31 | $336,913,842 | 3,161,729 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $311,699,074 | 3,134,229 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $324,684,574 | 3,143,427 | Shares | Sole | 2023-11-27 | |
| 2023-06-30 | $376,120,138 | 3,095,639 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $477,454,879 | 3,108,835 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $553,487,713 | 3,081,437 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $357,609,403 | 3,024,181 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $432,313,526 | 3,026,346 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $516,690,941 | 2,999,483 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $757,845,588 | 2,983,879 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $1,155,891,987 | 3,003,409 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $708,974,371 | 3,017,169 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $398,010,608 | 3,039,409 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $315,500,340 | 3,020,009 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $223,035,554 | 3,152,446 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $211,440,062 | 3,292,946 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $105,693,969 | 3,529,014 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||